Retinol-binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism

European Journal of Endocrinology

Volumn 157, Issue 2, 2007, Pages 201-207

  Hahn, Susanne ^c   Backhaus, Manuel ^a   Broecker Preuss, Martina ^a   Tan, Susanne ^a   Dietz, Tiina ^a   Kimmig, Rainer ^a   Schmidt, Markus ^a   Mann, Klaus ^a   Janssen, Onno E ^b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b NORTHWESTERN UNIVERSITY   (United States)

^c Endokrinologikum Ruhr   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; CORTICOTROPIN; ESTRADIOL; FOLLITROPIN; GLUCOSE; HYDROCORTISONE; LUTEINIZING HORMONE; PROLACTIN; RETINOL BINDING PROTEIN; RETINOL BINDING PROTEIN 4; SOMATOMEDIN; TESTOSTERONE; THYROTROPIN; UNCLASSIFIED DRUG;

ACNE; ADULT; ALOPECIA; AMENORRHEA; AREA UNDER THE CURVE; ARTICLE; BODY FAT; BODY MASS; CONTROLLED STUDY; DIET RESTRICTION; DISORDERS OF CARBOHYDRATE METABOLISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GERMANY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HUMAN; HYPERANDROGENISM; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; OBESITY; OLIGOMENORRHEA; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; OBESITY; POLYCYSTIC OVARY SYNDROME; RETINOL-BINDING PROTEINS; TESTOSTERONE;

EID: 34547790190     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-07-0143     Document Type: Article

References (31)

1. Hahn S, Tan S, Elsenbruch S, Quadbeck B, Herrmann BL, Mann K & Janssen OE. Clinical and biochemical characterization of women with polycystic ovary syndrome in North Rhine-Westphalia. Hormone and Metabolic Research 2005 37 438-444.
2. Holte J, Gennarelli G, Berne C, Bergh T & Lithell H. Elevated ambulatory day-time blood pressure in women with polycystic ovary syndrome: a sign of a pre-hypertensive state? Human Reproduction 1996 11 23-28.
3. Dunaif A, Segal KR, Futterweit W & Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989 38 1165-1174.
4. Legro RS, Kunselman AR, Dodson WC & Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. Journal of Clinical Endocrinology and Metabolism 1999 84 165-169.
5. Ehrmann DA, Barnes RE, Rosenfield RL, Cavaghan MK & Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999 22 141-146.
6. Pelusi B, Gambineri A & Pasquali R. Type 2 diabetes and the polycystic ovary syndrome. Minerva Ginecologica 2004 56 41-51.
7. Aronne LJ & Segal KR. Adiposity and fat distribution outcome measures: assessment and clinical implications. Obesity Research 2002 10 (Suppl 1) 14S-21S.
8. Yildiz BO, Yarali H, Oguz H & Bayraktar M. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2003 88 2031-2036.
9. Roldan B, San Millan JL & Escobar-Morreale HF. Genetic basis of metabolic abnormalities in polycystic ovary syndrome: implications for therapy. American Journal of Pharmacogenomics 2004 4 93-107.
10. Urbanek M, Legro RS, Driscoll DA, Azziz R, Ehrmann DA, Norman RJ, Strauss JF, III, Spielman RS & Dunaif A. Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. PNAS 1999 96 8573-8578.
11. Carmina E, Orio F, Palomba S, Longo RA, Cascella T, Colao A, Lombardi G, Rini GB & Lobo RA. Endothelial dysfunction in PCOS: role of obesity and adipose hormones. American Journal of Medicine 2006 119 356.e1-356.e6.
12. Orio F, Jr, Palomba S, Cascella T, Milan G, Mioni R, Pagano C, Zullo F, Colao A, Lombardi G & Vettor R. Adiponectin levels in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2003 88 2619-2623.
13. Yang Q, Graham TE, Mody N, Preitner F. Peroni OD, Zabolotny JM, Kotani K, Quadro L & Kahn BB. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005 436 356-362.
14. Haider DG, Schindler K, Mittermayer F, Muller M, Nowotny P, Rieger A, Luger A, Ludvik B & Wolzt M. Effect of rosiglitazone on visfatin and retinol-binding protein-4 plasma concentrations in HIV-positive patients. Clinical Pharmacology and Therapeutics 2007 81 580-585.
15. Haider DG, Schindler K, Prager G, Bohdjalian A, Luger A, Wolzt M & Ludvik B. Serum retinol-binding protein-4 is reduced after weight loss in morbidly obese subjects. Journal of Clinical Endocrinology and Metabolism 2006 92 1168-1171.
16. Munkhtulga L, Nakayama K, Utsumi N, Yanagisawa Y, Gotoh T, Omi T, Kumada M, Erdenebulgan B, Zolzaya K, Lkhagvasuren T & Iwamoto S. Identification of a regulatory SNP in the retinol binding protein 4 gene associated with type 2 diabetes in Mongolia. Human Genetics 2007 120 879-888.
17. Craig RL, Chu WS & Elbein SC. Retinol binding protein 4 as a candidate gene for type 2 diabetes and prediabetic intermediate traits. Molecular Genetics and Metabolism 2006 90 338-344.
18. Ludwig E. Classification of the types of androgenetic alopecia. (common baldness) occurring in the female sex. British Journal of Dermatology 1977 97 247-254.
19. ESHRE/ASRM. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility 2004 81 19-25.
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419.
21. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G & Quon MJ. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. Journal of Clinical Endocrinology and Metabolism 2000 85 2402-2410.
22. Matsuda M & DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999 22 1462-1470.
23. Goodarzi MO, Erickson S, Port SC, Jenurich RI & Korenman SG. Relative impact of insulin resistance and obesity on cardiovascular risk factors in polycystic ovary syndrome. Metabolism 2003 52 713-719.
24. Legro RS, Gnatuk CL, Kunselman AR & Dunaif A. Changes in glucose tolerance over time in women with polycystic ovary syndrome: a Controlled Study. Journal of Clinical Endocrinology and Metabolism 2005 90 3236-3242.
25. Panidis D, Rousso D, Kourtis A, Tsimas V, Papathanasiou K & Makedos G. Serum leptin levels in normal-weight and overweight women with polycystic ovary syndrome. Clinical and Experimental Obstetrics & Gynecology 2003 30 207-210.
26. Orio F, Jr, Lucidi P, Palomba S, Tauchmanova L, Cascella T, Russo T, Zullo F, Colao A, Lombardi G & De Feo P. Circulating ghrelin concentrations in the polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2003 88 942-945.
27. Janke J, Engeli S, Boschmann M, Adams F, Bohnke J, Luft FC, Sharma AM & Jordan J. Retinol-binding protein 4 in human obesity. Diabetes 2006 55 2805-2810.
28. Engeli S, Bohnke J, Gorzelniak K, Janke J, Schling P, Bader M, Luft FC & Sharma AM. Weight loss and the renin-angiotensin-aldosterone system. Hypertension 2005 45 356-362.
29. Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson. PA, Smith U & Kahn BB. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. New England Journal of Medicine 2006 354 2552-2563.
30. Cho YM, Youn BS, Lee H, Lee N, Min SS, Kwak SH, Lee HK & Park KS. Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care 2006 29 2457-2461.
31. Meigs JB, Panhuysen CI, Myers RH, Wilson PW & Cupples LA. A genome-wide scan for loci linked to plasma levels of glucose and HbA(1c) in a community-based sample of Caucasian pedigrees: the Framingham Offspring Study. Diabetes 2002 51 833-840.